Thought Leadership
Market access: Communicating the story effectively
February 15, 2012Medical Communications
By Andy Buckland – Principal Medical Writer at Abacus International Successful market access relies on a multitude of activities throughout …
SHL takes part in PharmTech.com’s “Pointed Debate: Expert Views on Injectables”
February 13, 2012Manufacturing and Production auto injector, auto-injector, pen injector, shl group
SHL recently had the opportunity to participate along with various other experts in the industry in a questionnaire held by …
SHL receives great response at the 2011 PDA in Basel
December 12, 2011Manufacturing and Production autoinjector, pda, pen injector, prefilled syringe, shl group
SHL successfully wrapped up this year’s exhibition at the PDA’s ” The Universe of Pre-filled Syringes and Injection Devices” 2011 …
Is global consistency in GCP interpretation an achievable goal?
November 16, 2011Research and Development
The potential benefits of standardisation in the conduct of an increasingly global clinical research effort are enormous. The promise of …
Quicker and slicker: new initiatives to improve clinical trial delivery
November 16, 2011Research and Development
Faster study set-up times, reduced bureaucracy and timely patient recruitment – these things are central to the success of commercial …
Infectious diseases versus clinical researchers. Who is winning?
November 16, 2011Research and Development
They were running hand in hand, and the Queen went so fast that it was all she could do to …
Full service CROs: a cost-effective option for global therapeutically focused clinical development expertise
November 16, 2011Research and Development
Skyrocketing clinical development costs are bad news for everyone, from pharmaceutical companies to patients. That’s why it’s crucial we find …
Emerging markets: comparing India and China as the future R&D hubs for the pharmaceutical industry
November 16, 2011Research and Development
The pharmaceutical industry is expanding worldwide. For the last few years, the emerging markets that offer the dynamics of growth …
Pharmacovigilance in the EU – recent and future changes
November 15, 2011Research and Development
Changes to both post-marketing and clinical trial requirements
The roles and responsibilities of an EEA qualified person for pharmacovigilance (QPPV)
November 15, 2011Research and Development
The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance are based on the current Directive 2001/83/EC and Vol …
Medical meetings and events – how to make the most of your budget
November 14, 2011Sales and Marketing
In today’s uncertain economic climate, much like every other form of marketing and business expenditure, event budgets are under scrutiny …
Creatures of habit: the long road to behavioural change
November 14, 2011Medical Communications
Budget cycles versus strong foundations Medical education has traditionally been about setting strong foundations for your brand, either pre-launch or to …
Call for collaborative creativity
November 14, 2011Medical Communications
Ever since clients started contracting work out to consultancies, marketing professionals on both sides of the arrangement have been seeking …
Engaging with the NHS – through patients?
November 14, 2011Medical Communications
Traditionally NHS joint working has been about pharma and the NHS working together in a collaborative and transparent fashion. These …
Understanding individual decision-making in health
November 14, 2011Medical Communications
Why now is the right time for pharma to get closer to patients and health consumers
Latest content
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
